Georgina V. Long, BSc, PhD, MBBS, co-medical director of Melanoma Institute Australia (MIA), chair of Melanoma Medical Oncology and Translational Research at MIA and Royal North Shore Hospital, University of Sydney, discusses the response rates in the CheckMate 067 trial (NCT01844505), which evaluated the combination of ipilimumab (Yervoy) and nivolumab (Opdivo) in patients with advanced […]
Archive | Video Reports
Patients in CheckMate 067 Demonstrate Durable Complete Responses
Posted in Melanoma News, Health Professionals, Video Reports
Evaluating Prognosis of Patients With Ocular Melanoma
Ragini Kudchadkar, MD, associate professor, Department of Hematology and Medical Oncology, associate director, Hematology and Medical Oncology Fellowship Program-Clinical/Service, Emory University School of Medicine, Winship Cancer Institute, discusses the overall prognosis of patients with ocular melanoma.
Posted in Melanoma News, Health Professionals, Video Reports
Dr. Kudchadkar on the Biological Differences Between Ocular and Cutaneous Melanoma
Omidubicel met the primary end point of time to neutrophil engraftment in patients with high-risk hematologic malignancies undergoing a bone marrow transplant, according to topline findings from a phase 3 trial announced by Gamida Cell Ltd., the developer of the investigational advanced cell therapy.
Posted in Melanoma News, Health Professionals, Video Reports
Dr. Pavlick on the COLUMBUS Trial in Metastatic Melanoma
Anna C. Pavlick, DO, professor in the Department of Medicine and Ronald O. Perelman Department of Dermatology, as well as the director of High Reliability Organization Initiatives and the co-director of the Melanoma Program at NYU Langone Health’s Perlmutter Cancer Center, discusses updated results from the COLUMBUS trial in metastatic melanoma.
Posted in Melanoma News, Health Professionals, Video Reports
